Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIDENT-MRI: Triple Pill for cerebral small vessel disease in ICH patients
NCT03783754Phase 3Terminated
- Sponsor
- The George Institute for Global Health
- Start
- Aug 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine, indapamide in Cerebral Small Vessel Disease (CSVD), stroke, sponsored by The George Institute for Global Health. Started Aug 2018; status: terminated.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
Cerebral Small Vessel Disease (CSVD)stroke
Beyond the preview
Go deeper on NCT03783754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783754.